This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
Here's Why You Should Hold OPK Stock in Your Portfolio for Now
by Zacks Equity Research
OPK rides on RAYALDEE strength and partnerships, but revenue decline, losses, and reliance on a single drug cloud its near-term outlook.
ISRGPositive Net Change ALGNPositive Net Change CAHNegative Net Change OPKNo Net Change
medical medical-devices
CAH Posts Strong Cash Flow, Eyes Next Steps in Capital Deployment
by Indrajit Bandyopadhyay
CAH's $1.8 billion free cash flow fuels buybacks, dividends, and reinvestment, as Cardinal Health eyes disciplined capital deployment and targeted growth opportunities.
CNMDPositive Net Change ALGNPositive Net Change CAHNegative Net Change
medical medical-devices
Reasons to Retain Avanos Medical Stock in Your Portfolio for Now
by Zacks Equity Research
AVNS gains on strong SNS and PMR growth, M&A and cost actions, but tariff risks and segment headwinds may weigh on near-term performance.
ISRGPositive Net Change CAHNegative Net Change PAHCPositive Net Change AVNSPositive Net Change
medical medical-devices
GEHC & Springbok Collaborate on MRI Muscle Analysis for Sports
by Zacks Equity Research
GE HealthCare teams with Springbok to pair MRI tech with AI muscle analytics, aiming to redefine how muscle health is measured and visualized.
ISRGPositive Net Change CAHNegative Net Change PAHCPositive Net Change GEHCPositive Net Change
medical medical-devices
Here's Why You Should Hold Solventum Stock in Your Portfolio Now
by Zacks Equity Research
SOLV rides on strong segment demand, innovation push and cost savings plan, but tariffs and rising input costs cloud margin outlook.
ISRGPositive Net Change ALGNPositive Net Change CAHNegative Net Change SOLVPositive Net Change
medical medical-devices
Intuitive Surgical and Lennar have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Intuitive Surgical shines on growth and earnings beats, while Lennar faces falling sales, margins, and a prolonged housing market slump.
ISRGPositive Net Change LENNegative Net Change PLTRPositive Net Change BBAINegative Net Change
artificial-intelligence computers medical-devices tech-stocks
Hologic's Women's Health Index Flags Alarming Gaps in STI Screening
by Moumi Mondal
HOLX's Global Women's Health Index shows STI testing stagnates at 10%, leaving nearly 2 billion women at risk despite gains in other screenings.
HOLXPositive Net Change QGENPositive Net Change GEHCPositive Net Change
medical medical-devices
Bull of the Day: Intuitive Surgical (ISRG)
by Tracey Ryniec
Hide out in this top growth stock.
ISRGPositive Net Change
medical-devices
Here's Why You Should Add PacBio Stock to Your Portfolio Now
by Zacks Equity Research
PACB gains from strong Q4 results and expanding sequencing portfolio, but prolonged purchasing cycles and funding constraints remain a key overhang.
ISRGPositive Net Change ALGNPositive Net Change CAHNegative Net Change PACBPositive Net Change
medical medical-devices
HealthEquity Stock Gains as Q4 Earnings Top Estimates, Revenues Up Y/Y
by Zacks Equity Research
HQY stock rises after Q4 earnings beat, along with strong HSA growth and higher margins.
ISRGPositive Net Change ALGNPositive Net Change CAHNegative Net Change HQYPositive Net Change
earnings medical medical-devices